Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Quinoline antimalarials decrease the rate of beta-hematin formation.

Timothy J Egan1, Kanyile K Ncokazi

  • 1Department of Chemistry, University of Cape Town, Private Bag, Rondebosch 7701, South Africa. tegan@science.uct.ac.za

Journal of Inorganic Biochemistry
|June 2, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exploration of Antiplasmodium Chemical Space Identifies New Inhibitors of β-Hematin Formation from Areas of Enrichment.

ChemMedChem·2026
Same author

Heme processing in the malaria parasite, Plasmodium falciparum: a time-dependent basal-level analysis.

Communications biology·2025
Same author

Synthesis and SAR Studies of Acyl-Thiourea Platinum(II) Complexes Yield Analogs with Dual-Stage Antiplasmodium Activity.

ACS medicinal chemistry letters·2025
Same author

Heme Detoxification in the Malaria Parasite <i>Plasmodium falciparum</i>: A Time-Dependent Basal-Level Analysis.

bioRxiv : the preprint server for biology·2025
Same author

Corrigendum to "<i>In vitro</i> antiplasmodium and antitrypanosomal activities, β-haematin formation inhibition, molecular docking and DFT computational studies of quinoline-urea-benzothiazole hybrids" [Heliyon Volume 10, Issue 19, October 2024, Article e38434].

Heliyon·2025
Same author

<i>In vitro</i> antiplasmodium and antitrypanosomal activities, β-haematin formation inhibition, molecular docking and DFT computational studies of quinoline-urea-benzothiazole hybrids.

Heliyon·2024

Quinoline antimalarial drugs inhibit beta-hematin formation, but this inhibition is time-dependent. These drugs appear to slow down hemozoin formation rather than irreversibly blocking it.

Area of Science:

  • Medicinal Chemistry
  • Parasitology
  • Biochemistry

Background:

  • Beta-hematin formation is a key target for antimalarial drugs.
  • Quinoline-based drugs are widely used to treat malaria.
  • Understanding drug-heme interactions is crucial for developing new antimalarials.

Purpose of the Study:

  • To investigate the time-dependent inhibition of beta-hematin formation by quinoline antimalarial drugs.
  • To compare the inhibitory effects of chloroquine, amodiaquine, quinidine, and quinine.
  • To elucidate the mechanism of action of these drugs on hemozoin formation.

Main Methods:

  • In vitro assay for beta-hematin formation at 60°C in 4.5M acetate buffer (pH 4.5).
  • Spectrophotometric detection of unreacted hematin.

Related Experiment Videos

  • Infrared spectroscopy and X-ray powder diffraction for structural confirmation.
  • Scanning electron microscopy (SEM) for crystal morphology analysis.

    • Main Results:

    • All tested quinoline drugs inhibited beta-hematin formation, but inhibition decreased with longer incubation times.
    • IC(50) values increased significantly with incubation time for chloroquine and amodiaquine, but less so for quinine and quinidine.
    • SEM revealed altered and more uniform beta-hematin crystal morphology in the presence of chloroquine.

    Conclusions:

    • Quinoline antimalarial drugs likely decrease the rate of hemozoin formation rather than irreversibly blocking it.
    • The observed time-dependent inhibition and sigmoidal dose-response suggest a dynamic interaction between drugs and heme.
    • These findings provide insights into the mechanism of resistance and drug efficacy.